CELL INTELLIGENCE · 肿瘤细胞治疗研究

慢性淋巴细胞白血病中的 Richter 转化：当前治疗挑战与不断演变的疗法

Richter Transformation in Chronic Lymphocytic Leukemia: Current Treatment Challenges and Evolving Therapies.

RORing CAR-T 细胞在实体瘤与血液肿瘤中：相同却不同

RORing CAR T Cells in Solid and Hematologic Cancers: Same but Different.

ROR1 特异性 CAR-T 细胞治疗晚期血液系统与上皮恶性肿瘤的 I 期研究

Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies.

ROR1 CAR-T 细胞在大多数患者中耐受良好。

各种成人白血病和淋巴瘤类型中 ROR1 水平的肿瘤评估

Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types.

释放潜力：ROR1 靶向肿瘤治疗的进展与未来前景

Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies.

套细胞淋巴瘤的当前治疗

Current Treatments in Mantle Cell Lymphoma.

2022 年套细胞淋巴瘤：分子发病机制、风险分层、临床策略及当前与新型治疗的综合更新

Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatment

2022 年套细胞淋巴瘤的新方向

New Directions for Mantle Cell Lymphoma in 2022.

复发/难治性套细胞淋巴瘤的治疗选择

Therapeutic options for relapsed/refractory mantle cell lymphoma.